Chemed Cost of Goods Sold 2010-2024 | CHE

Chemed annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Chemed cost of goods sold for the quarter ending June 30, 2024 was $0.390B, a 4.16% increase year-over-year.
  • Chemed cost of goods sold for the twelve months ending June 30, 2024 was $1.496B, a 3.76% increase year-over-year.
  • Chemed annual cost of goods sold for 2023 was $1.466B, a 6.99% increase from 2022.
  • Chemed annual cost of goods sold for 2022 was $1.37B, a 0.03% increase from 2021.
  • Chemed annual cost of goods sold for 2021 was $1.369B, a 0.63% decline from 2020.
Chemed Annual Cost of Goods Sold
(Millions of US $)
2023 $1,466
2022 $1,370
2021 $1,369
2020 $1,378
2019 $1,321
2018 $1,228
2017 $1,151
2016 $1,115
2015 $1,088
2014 $1,035
2013 $1,009
2012 $1,033
2011 $970
2010 $906
2009 $835
Chemed Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $390
2024-03-31 $385
2023-12-31 $358
2023-09-30 $362
2023-06-30 $374
2023-03-31 $371
2022-12-31 $350
2022-09-30 $347
2022-06-30 $337
2022-03-31 $337
2021-12-31 $336
2021-09-30 $342
2021-06-30 $350
2021-03-31 $340
2020-12-31 $335
2020-09-30 $339
2020-06-30 $352
2020-03-31 $352
2019-12-31 $347
2019-09-30 $328
2019-06-30 $324
2019-03-31 $322
2018-12-31 $312
2018-09-30 $305
2018-06-30 $306
2018-03-31 $305
2017-12-31 $291
2017-09-30 $288
2017-06-30 $286
2017-03-31 $285
2016-12-31 $279
2016-09-30 $282
2016-06-30 $276
2016-03-31 $278
2015-12-31 $276
2015-09-30 $272
2015-06-30 $271
2015-03-31 $269
2014-12-31 $263
2014-09-30 $256
2014-06-30 $257
2014-03-31 $258
2013-12-31 $246
2013-09-30 $243
2013-06-30 $255
2013-03-31 $264
2012-12-31 $262
2012-09-30 $257
2012-06-30 $257
2012-03-31 $257
2011-12-31 $248
2011-09-30 $245
2011-06-30 $240
2011-03-31 $237
2010-12-31 $235
2010-09-30 $228
2010-06-30 $224
2010-03-31 $219
2009-12-31 $211
2009-09-30 $209
2009-06-30 $207
2009-03-31 $207
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.694B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00